DoW Vision, Clinical Trial Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 4, 2026
- Amount
- Program total $2.6M
- Closes
- Nov 12, 2026 (in 60 days)
Similar opportunities open now
- DoW Vision, Translational Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 60 days
- DoW Vision, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 60 days
- DoW Peer Reviewed Medical, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 9 days
- DoW Peer Reviewed Cancer, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 22 days
- DoW Autism Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 39 days
Classification and identifiers
- Solicitation number
- HT942526VRPCTA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $2.6M
Who can apply
About this opportunity
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas . Distinctive Features: · For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. In addition, applicants must provide documentation of communication from the Regulatory Agency indicating that the IND/IDE or equ...